Clinical Trial Update: Luminal Fructose Kinetics (MARTINI Study) [Phase 2]

View source ↗

Summary

Phase 2 trial MARTINI evaluating luminal fructose kinetics in metabolic dysfunction-associated steatotic liver disease is currently recruiting at Academisch Med…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: MASLD | Phase 2 | Status: RECRUITING